The potential for YAP to serve as a therapeutic target in oral cancer has drawn increasing interest recently, reflecting important observations about the expression and the putative oncogenic functions of YAP in cancers [120]. This evidence concerns the gene YAP1 and lip and oral cavity carcinoma.